Charles Schwab Investment Management Inc. Acquires 6,317 Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Charles Schwab Investment Management Inc. increased its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 0.1% during the first quarter, HoldingsChannel.com reports. The fund owned 4,711,280 shares of the real estate investment trust’s stock after buying an additional 6,317 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Sabra Healthcare REIT were worth $82,306,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of SBRA. Wells Fargo & Company MN lifted its holdings in Sabra Healthcare REIT by 13.4% during the fourth quarter. Wells Fargo & Company MN now owns 349,804 shares of the real estate investment trust’s stock worth $6,059,000 after acquiring an additional 41,227 shares during the period. Envestnet Asset Management Inc. lifted its holdings in Sabra Healthcare REIT by 6.9% during the fourth quarter. Envestnet Asset Management Inc. now owns 559,789 shares of the real estate investment trust’s stock worth $9,696,000 after acquiring an additional 36,104 shares during the period. Federated Hermes Inc. lifted its holdings in Sabra Healthcare REIT by 39.7% during the fourth quarter. Federated Hermes Inc. now owns 22,123 shares of the real estate investment trust’s stock worth $383,000 after acquiring an additional 6,282 shares during the period. Invesco Ltd. lifted its holdings in Sabra Healthcare REIT by 9.9% during the fourth quarter. Invesco Ltd. now owns 2,556,218 shares of the real estate investment trust’s stock worth $44,274,000 after acquiring an additional 229,708 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in Sabra Healthcare REIT during the fourth quarter worth $887,000. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Stock Performance

Shares of SBRA opened at $18.53 on Thursday. The firm has a market cap of $4.44 billion, a PE ratio of 24.38, a PEG ratio of 1.54 and a beta of 0.86. The stock’s fifty day moving average price is $18.31 and its two-hundred day moving average price is $17.59. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%. The company had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. During the same period in the previous year, the company posted $0.36 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT’s payout ratio is presently 157.89%.

Insider Activity

In related news, Director Michael J. Foster sold 11,000 shares of the business’s stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director directly owned 64,725 shares in the company, valued at approximately $1,179,289.50. The trade was a 14.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.20% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on SBRA. JMP Securities boosted their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th. Scotiabank boosted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research note on Monday, June 23rd. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $20.00.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.